Jordan Krall
About Jordan Krall
Jordan Krall is a Principal Scientist currently employed at MOMA Therapeutics, where he has worked since 2021. He has extensive experience in the pharmaceutical industry, having held positions at Agios Pharmaceuticals and Servier Pharmaceuticals, and has a strong academic background with degrees from the University of Oxford, Harvard University, and Amherst College.
Current Role at MOMA Therapeutics
Jordan Krall serves as Principal Scientist at MOMA Therapeutics, a position he has held since 2021. In this role, he contributes to the research and development of innovative therapeutic solutions. His expertise in chemistry and chemical biology supports the company's mission to advance drug discovery and development.
Previous Experience at Agios Pharmaceuticals
Jordan Krall worked at Agios Pharmaceuticals in various capacities. He served as Senior Scientist from 2017 to 2020, followed by a role as Associate Director/Principal Scientist from 2020 to 2021. His tenure at Agios Pharmaceuticals spanned three years, during which he focused on advancing scientific research in the field of pharmaceuticals.
Experience at Servier Pharmaceuticals
Krall held the position of Associate Director/Principal Scientist at Servier Pharmaceuticals for a brief period of five months in 2021. His work in this role was based in Cambridge, Massachusetts, where he continued to apply his scientific expertise in the pharmaceutical industry.
Academic Background and Education
Jordan Krall has a strong academic background in chemistry. He earned a Bachelor’s Degree in Chemistry from Amherst College from 1997 to 2001. He then attended the University of Oxford, where he completed an MSc in Chemistry as a Rhodes Scholar from 2001 to 2003. Krall furthered his education at Harvard University, obtaining a Ph.D. in Chemistry and Chemical Biology from 2003 to 2009.
Postdoctoral Fellowship at Whitehead Institute
Krall completed a postdoctoral fellowship at the Whitehead Institute from 2009 to 2017. This eight-year tenure allowed him to engage in advanced research, contributing to the scientific community and enhancing his expertise in the field of biochemistry.